AIM AIM ImmunoTech Future Price to Earnings
AIM ImmunoTech focuses on developing Ampligen-based immunomodulators to combat viruses and oncology. The issuer's forward P/E visualizes the market value of the expected profit share, while 0.00 shows the current value of this metric. Robotic screening systems ensure development efficiency, and business growth relies on research alliances with medical consortia without the acquisition of startups.
aimimmuno.com (AIM) - metric breakdowns and financial figures
- stock quotes and analyst forecast:
- market capitalization data:
- balance sheet equity data:
- issuer credit burden and liquidity indicators:
- company profitability and valuation multiples indicators:
AIM - Net Income|Future Profit AIM ImmunoTech|AIM - Company Value to Net Income|Forward P/E Multiple AIM ImmunoTech|AIM - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization AIM ImmunoTech, Inc.|AIM - Operating profit before deduction of amortization|Earnings per share for the last twelve months AIM ImmunoTech|AIM - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months aimimmuno.com|AIM - Earnings growth in current year|Net earnings per share growth forecast for next year AIM ImmunoTech
Analysis of all company metrics:AIM ImmunoTech
The market assesses the potential of AIM ImmunoTech through the lens of expected earnings, where the company's forward P/E compares the current quote with yield forecasts to identify value inflection points. Analyzing the forward P/E of AIM ImmunoTech allows for an evaluation of intellectual property protection efficiency and cost transparency, determining whether a low multiple represents a defensive asset or a signal of stagnation within the biopharmaceutical business.
Analysis of competing companies
Forward P/E Multiple ARGX|Market Cap to Projected Earnings BioNTech Inc.|Future Price to Earnings abivax.com ABVX|ADMA - Projected Price to Earnings|PTGX - Future Price to Earnings|immunovant.com (IMVT) - Projected Price to Earnings|KNSA (Kiniksa) - Projected Price to Earnings|Grifols SA (GRFS) - Forward P/E Multiple|Future Price to Earnings Adaptive Biotechnologies Corp|Price to Future Earnings Ratio CLDX (Celldex Corp)|Forward P/E Multiple AUPH|BCRX - Projected Price to Earnings Ratio|Forward P/E Multiple VERA (Vera Therapeutics)|Forward P/E Multiple Dianthus Therapeutics Inc DNTH|Pharvaris Corp - Forward P/E Multiple|Market Cap to Projected Earnings AbCellera Biologics ABCL|Tourmaline Bio, Inc. (TRML) - Future Price to Earnings|Projected Price to Earnings precigen.com|Projected Price to Earnings PHAR|NKTR: Future Price to Earnings Multiple|Forward P/E Multiple UPB|Market Cap to Projected Earnings Zenas Corp|Future Price to Earnings Immunome, Inc. IMNM|GOSS - Projected Price to Earnings|KALV - Future Price to Earnings|Septerna, Inc. (SEPN) - Projected Price to Earnings|PVLA (Pieris Pharmaceuticals Inc) - Projected Price to Earnings|Savara Pharma (SVRA) - Forward P/E Multiple|Future Price to Earnings Rigel Pharmaceuticals|Price to Future Earnings Ratio ANAB (anaptysbio.com)|Future Price to Earnings Astria Therapeutics, Inc. (ATXS)|ENGN - Projected Price to Earnings Ratio|RAPT Therapeutics, Inc. - Projected Price to Earnings|Market Cap to Future Earnings Ratio JBIO (Aerovate Therapeutics, Inc.)|Aclaris Therapeutics - Forward P/E Multiple|Projected Price to Earnings Ratio kyvernatx.com|TLSA: Forward P/E Multiple|Projected Price to Earnings Cabaletta Bio Inc.|VTYX (Ventyx Bio) - Forward P/E Multiple|THTX: Future Price to Earnings Multiple|Forward P/E Multiple AVTX|Forward P/E Multiple eledon.com (ELDN)|Forward P/E Multiple AGEN (Agenus Inc.)|Market Cap to Projected Earnings Climb Bio Inc. (CLYM)|ZURA - Future Price to Earnings|aTyr Pharmaceuticals (ATYR) - Projected Price to Earnings|adagene.com (ADAG) - Future Price to Earnings|Price to Expected Earnings Ratio IMA (Ikena Oncology)|STTK (Shattuck Labs Inc) - Forward P/E Multiple|EQ: Future Price to Earnings Multiple|Forward P/E Multiple CNTB|Forward P/E Multiple immunic-therapeutics.com (IMUX)|Future Price to Earnings Atara Bio ATRA|Future Price to Earnings Multiple IFRX|XFOR - Future Price to Earnings|Adicet Bio (ACET) - Projected Price to Earnings|CELU: Forward P/E Multiple|INmune Bio Corporation (INMB) - Forward P/E Multiple|Projected Price to Earnings BRNS|KZR: Future Price to Earnings Multiple|Forward P/E Multiple SABS|Market Cap to Projected Earnings Akari Therapeutics PLC|Future Price to Earnings Enlivex Therapeutics Ltd. ENLV|QTTB - Projected Price to Earnings|GOVX - Future Price to Earnings|edesabiotech.com (EDSA) - Projected Price to Earnings|IBIO (iBio) - Projected Price to Earnings|Carisma Therapeutics Inc. (CARM) - Forward P/E Multiple|Future Price to Earnings XTL Biopharmaceuticals, Ltd.|Price to Future Earnings Ratio BOLT (Bolt Bio)|Forward P/E Multiple HCWB|APVO - Projected Price to Earnings Ratio|Forward P/E Multiple ADTX (Aditxt, Inc.)|Forward P/E Multiple GRI Bio Inc GRI|XORTX - Forward P/E Multiple|Market Cap to Projected Earnings Vyome Therapeutics HIND|Revelation Biosciences (REVB) - Future Price to Earnings|Projected Price to Earnings indaptusrx.com|Projected Price to Earnings SCNI|CALI: Future Price to Earnings Multiple|Forward P/E Multiple AFMD|Market Cap to Projected Earnings allakos.com|Future Price to Earnings HOOKIPA Pharma HOOK|IGMS - Projected Price to Earnings|ITOS - Future Price to Earnings|Ocean Biomedical Inc (OCEA) - Projected Price to Earnings|TCBP (TC BioPharm (Holdings) PLC) - Projected Price to Earnings|Third Harmonic Bio Inc (THRD) - Forward P/E Multiple
